Clinical Trial Update: A Study to Evaluate the Safety and Effect of STC3141 Continuous Infusion in Subjects With Severe Corona Virus Disease 2019（COVID-19）Pneumonia [Phase 2]

View source ↗

Summary

Phase 2 trial completed evaluating safety and effect of STC3141 continuous infusion in severe COVID-19 pneumonia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Pneumonia

Drugs mentioned

• STC3141 (STC3141)

Snippet

Sponsor: Grand Medical Pty Ltd. | Conditions: Severe COVID-19 Pneumonia | Phase 2 | Status: COMPLETED